Infinity Pharmaceuticals, Inc.
INFIQ · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $49,533 | $192,594 | $126,899 | $54,704 |
| - Cash | $38,313 | $80,726 | $28,593 | $22,260 |
| + Debt | $48,130 | $51,060 | $24,332 | $31,933 |
| Enterprise Value | $59,350 | $162,928 | $122,638 | $64,377 |
| Revenue | $2,593 | $1,858 | $1,719 | $3,049 |
| % Growth | 39.6% | 8.1% | -43.6% | – |
| Gross Profit | $1,030 | $738 | $682 | -$4,259 |
| % Margin | 39.7% | 39.7% | 39.7% | -139.7% |
| EBITDA | -$43,731 | -$44,602 | -$37,564 | -$44,329 |
| % Margin | -1,686.5% | -2,400.5% | -2,185.2% | -1,453.9% |
| Net Income | -$44,369 | -$45,262 | -$40,492 | -$47,057 |
| % Margin | -1,711.1% | -2,436.1% | -2,355.6% | -1,543.4% |
| EPS Diluted | -0.5 | -0.53 | -0.68 | -0.83 |
| % Growth | 5.7% | 22.1% | 18.1% | – |
| Operating Cash Flow | -$42,431 | -$40,618 | -$35,739 | -$41,530 |
| Capital Expenditures | -$17 | -$11 | -$43 | -$2,327 |
| Free Cash Flow | -$42,448 | -$40,629 | -$35,782 | -$43,857 |